Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionVestmark Advisory Solutions, Inc.
Latest Disclosed Ownership79,612 shares
Latest Disclosed Value $ 12,160,991
Vestmark Advisory Solutions, Inc. reports 15.56% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Vestmark Advisory Solutions, Inc. filed a 13F-HR form disclosing ownership of 79,612 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $12,160,733 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 94,282 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -15.56% during the quarter. The current value of the position is $11,437,060 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 79,612 -14,670 -15.56 12,161 -6.45 0.0836
2026-02-06 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 94,282 84,944 909.66 12,999 985.88 0.1754
2025-11-10 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,338 -4,293 -31.49 1,198 -27.41 0.0228
2025-08-06 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 13,631 5,217 62.00 1,650 75.99 0.0238
2025-05-13 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,414 -150 -1.75 938 12.48 0.0242
2025-02-06 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,564 65 0.76 833 -14.74 0.0287
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,499 -3,402 -28.59 978 -22.83 0.0364
2024-08-12 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,901 -4,211 -26.14 1,267 -18.74 0.0529
2024-05-15 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 16,112 -754 -4.47 1,559 -8.51 0.0671
2024-02-06 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 16,866 2,366 16.32 1,703 15.38 0.0865
2023-11-06 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 14,500 -31,950 -68.78 1,477 -68.51 0.1074
2023-08-07 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 46,450 -3,331 -6.69 4,687 2.34 0.1785
2023-05-09 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 49,781 96 0.19 4,580 1.62 0.1983
2023-01-20 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 49,685 -490 -0.98 4,508 18.17 0.2196
2022-11-03 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 50,175 15,117 43.12 3,814 28.68 0.2126
2022-08-04 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 35,058 -1,676 -4.56 2,964 -8.06 0.1693
2022-04-27 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 36,734 5,558 17.83 3,224 18.23 0.1825
2022-01-31 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 31,176 1,261 4.22 2,727 11.49 0.1539
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 29,915 1,948 6.97 2,446 -4.15 0.1657
2021-08-09 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 27,967 2,782 11.05 2,552 18.53 0.1816
2021-05-10 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 25,185 -2,576 -9.28 2,153 -17.89 0.1910
2021-02-04 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 27,761 -5,468 -16.46 2,622 -9.27 0.2942
2020-10-19 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 33,229 -675 -1.99 2,890 -2.40 0.3882
2020-08-13 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 33,904 -306 -0.89 2,961 4.96 0.4582
2020-05-06 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 34,210 -130 -0.38 2,821 -13.25 0.5515
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 34,340 2,802 8.88 3,252 18.64 0.6673
2019-11-05 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 31,538 2,376 8.15 2,741 2.93 0.4444
2019-08-20 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 29,162 2,305 8.58 2,663 3.14 0.4557
2019-05-14 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 26,857 26,857 2,582 0.4604
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.